We’re building a new category of diagnostics


Late diagnosis is responsible for three of the top ten causes of death.

One of those conditions is sepsis. More patients die from sepsis than AIDS, prostate cancer and breast cancer combined. Early diagnosis is essential to fight conditions like sepsis, but biochemical limitations mean that patients often get caught too late.

Dascena develops algorithms as a new category of diagnostics to catch patients earlier when they can be effectively treated.


Bringing algorithms to the bedside.

Our founder, Ritankar Das, began developing algorithms to help diagnose complex clinical conditions while a PhD student at the University of Cambridge. His mentor, Dr. P. Roy Vagelos, encouraged him to start a company in order to bring these life-saving algorithms to patients, and became our first investor. Subsequently, the company received four grants from the National Institutes of Health (NIH) to develop the technology and perform clinical trials. Today, our algorithms are used by health systems across the US and helps save thousands of lives.

Our Advisors

Dr. John Mather

Senior astrophysicist and project scientist at NASA’s Goddard Space Flight Center. Nobel Laureate, 2006.

Dr. P. Roy Vagelos

Chairman, Regeneron Pharmaceuticals. Former Chairman and CEO, Merck & Co., Inc.

Steve Goldman

Founder and CEO, Korrio, Inc. (acquired by TeamSnap). Former CEO, Isilon Systems, Inc. (acquired by EMC).

Join Our Team

Be a part of a team that helps save lives every day.


Interested in learning more?